Blepharokeratitis is a chronic external ocular and adnexal inflammatory con
dition marked by erythematous and edematous lid margins, lid margin crustin
g and scaling, meibomian gland inflammation and inspissation, and conjuncti
val hyperemia. The associated keratitis usually involves the inferior corne
a and is characterized by punctate epithelial keratopathy and marginal stro
mal infiltrates. The inflammation sometimes leads to corneal thinning, scar
ring, and vascularization. The standard therapy for adult blepharokeratitis
includes lid hygiene, topical corticosteroid preparations, and topical ant
ibiotics. Oral tetracycline and its analogues, doxycycline and minocycline,
are used in adults to treat associated meibomian gland dysfunction. Wherea
s blepharitis is common in children, blepharokeratitis is rare and is often
associated with severe ocular and psychosocial morbidity. Treatment of you
ths may be problematic because of poor compliance with lid hygiene and ther
apy that includes drops and ointment.(1) Furthermore, the use of tetracycli
ne and its analogues is contraindicated in children aged less than 8 years
because it may cause dental enamel abnormalities. Isolated case reports hav
e suggested that erythromycin may be a reasonable alternative to tetracycli
ne in childhood blepharokeratitis.(2,3) We report on the successful treatme
nt of this condition with oral erythromycin in 5 children.